| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $35.71B | $36.29B | $33.13B |
| YoY Revenue Growth % | -1.6% | +9.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.98B | $5.26B | $6.52B |
| Operating Margin % | 11.1% | 14.5% | 19.7% |
| Net Income (GAAP) | $3.37B | $4.46B | $4.20B |
| EBITDA (Normalized) | $5.34B | $6.81B | $7.72B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.49B | $6.60B | $6.64B |
| Capital Expenditures (CapEx) | $1.69B | $1.93B | $1.49B |
| Free Cash Flow (FCF) | $4.79B | $4.67B | $5.15B |
| FCF Margin % | 13.4% | 12.9% | 15.5% |
| Return on Invested Capital (ROIC %) | 10.5% | 15.5% | 19.5% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $9.74B | $11.02B | $10.22B |
| Total Stockholders' Equity | $26.11B | $21.13B | $20.97B |